A detailed history of Profund Advisors LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Profund Advisors LLC holds 46,052 shares of CYTK stock, worth $2.3 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
46,052
Previous 51,921 11.3%
Holding current value
$2.3 Million
Previous $2.81 Million 13.58%
% of portfolio
0.09%
Previous 0.11%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$51.22 - $60.16 $300,610 - $353,079
-5,869 Reduced 11.3%
46,052 $2.43 Million
Q2 2024

Aug 13, 2024

BUY
$47.86 - $75.05 $1.22 Million - $1.91 Million
25,400 Added 95.77%
51,921 $2.81 Million
Q1 2024

May 08, 2024

SELL
$63.75 - $108.06 $1.35 Million - $2.29 Million
-21,228 Reduced 44.46%
26,521 $1.86 Million
Q4 2023

Feb 14, 2024

BUY
$26.88 - $83.49 $50,265 - $156,126
1,870 Added 4.08%
47,749 $3.99 Million
Q3 2023

Nov 13, 2023

BUY
$29.46 - $36.61 $13,168 - $16,364
447 Added 0.98%
45,879 $1.35 Million
Q2 2023

Aug 10, 2023

BUY
$32.62 - $40.75 $174,777 - $218,338
5,358 Added 13.37%
45,432 $1.48 Million
Q1 2023

May 11, 2023

BUY
$33.36 - $45.71 $1.15 Million - $1.57 Million
34,405 Added 606.9%
40,074 $1.41 Million
Q4 2022

Feb 02, 2023

SELL
$35.77 - $51.11 $20,531 - $29,337
-574 Reduced 9.19%
5,669 $259,000
Q3 2022

Nov 04, 2022

BUY
$38.54 - $54.52 $18,383 - $26,006
477 Added 8.27%
6,243 $302,000
Q2 2022

Aug 01, 2022

SELL
$33.93 - $48.92 $36,949 - $53,273
-1,089 Reduced 15.89%
5,766 $227,000
Q1 2022

May 10, 2022

SELL
$29.74 - $46.0 $21,293 - $32,936
-716 Reduced 9.46%
6,855 $252,000
Q4 2021

Feb 08, 2022

SELL
$34.35 - $46.38 $13,293 - $17,949
-387 Reduced 4.86%
7,571 $345,000
Q3 2021

Nov 12, 2021

BUY
$18.54 - $35.74 $147,541 - $284,418
7,958 New
7,958 $284,000
Q4 2018

Feb 14, 2019

SELL
$5.91 - $9.29 $59,271 - $93,169
-10,029 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$6.4 - $9.85 $6,182 - $9,515
-966 Reduced 8.79%
10,029 $99,000
Q2 2018

Aug 13, 2018

BUY
$6.9 - $9.9 $75,865 - $108,850
10,995 New
10,995 $91,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.69B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.